HAX’s VC-Founder Industry Hard Tech Matchup is now accepting applications. Register today!

Back
Solvay joins the Genesis Consortium to support SOSV’s IndieBio startups
Back
Lauren McCranie
Lauren McCranie

Solvay Ventures, the venture capital fund of Solvay, announced that the fund has joined the Genesis Consortium to support startups in SOSV’s IndieBio startup development program, which holds a portfolio of early-stage, venture-backed companies innovating in planetary and human health.

The Genesis Consortium, founded by SOSV and Mayfield, is a global alliance of venture capital firms and corporations dedicated to supporting startups that leverage biotechnology to promote human and planetary health.

Over the years, Solvay Ventures has demonstrated interest in Indiebio’s graduate companies, which represent a growing number of early-stage ventures with ties to Solvay’s commitment to innovating in chemical biotechnology.

“We are thrilled to join the Genesis Consortium and SOSV’s IndieBio, which will reinforce our position in biotech and help us better serve our customers as we reinvent chemistry through biotechnology,” said Solvay CEO Ilham Kadri.

“On the journey to reshape the global economy for sustainability, it’s fantastic to have Solvay as a key partner,” said Sean O’Sullivan, founder and managing general partner at SOSV. “Using efficiencies only possible through biology, IndieBio startups are reinventing the world’s means of production of foods and materials.  It’s a great sign for the future that materials and chemistry companies with tens of billions in revenue, like Solvay, are joining side by side with IndieBio startups to create a healthier future.”

Did you know?